Company profile
Bespoke Extracts, Inc.
OTC: BSPK · Healthcare · Drug Manufacturers - Specialty & Generic
#866 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 17GM —SS 30
v0.1 · 25/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, workforce scale
Methodology →Revenue TTM
$1.4M
Rev growth YoY (TTM)
+284.5%
Net income (FY)
-$1.0M
Employees
2
as of 2026-08-25
Market cap
$10.1k
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.1M$1.1M2024
Net income-$1.0M-$1.0M2024
Operating income-$994.6k-$994.6k2024
Total assets$359.1k$359.1k2024
Liabilities$2.5M$2.5M2024
Equity-$2.1M-$2.1M2024
Revenue trend
FY2018 – FY2024 · USD
FY18
FY19
FY22
FY22
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Bespoke Extracts, Inc.’s revenue?
Bespoke Extracts, Inc. booked $1.1M in FY2024 revenue, growing 42% year over year — faster than most Healthcare companies we track, at a -92.8% net margin.
Peers · Healthcare
Ampio Pharmaceuticals, Inc.——PetVivo Holdings, Inc.38DRenovoRx, Inc.32DKaleido Biosciences, Inc.——White River Energy Corp.——Matinas BioPharma Holdings, Inc.32DNeighbors
Arapahoe →Key facts
CEOMichael R. Feinsod
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersAurora, CO
ExchangeOTC: BSPK
Employees2
IPO date2008-02-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.